RAMM Pharma Corp. acquires European hemp manufacturer
September 6, 2022 By Haley Nagasaki
(Globe Newswire) Toronto — RAMM Pharma Corp. is pleased to announce that today it has acquired all of the issued and outstanding shares of HemPoland from The Green Organic Dutchman Holdings Ltd. for cash consideration of C$1.2 million.
HemPoland is a leading European manufacturer and marketer of premium hemp products. The acquisition by Ramm provides access to HemPoland’s distribution network, recognized premium brands, hemp oil extraction technologies, and an additional synergistic foothold into the European market following the acquisition of Sicily-based Canapar Corp. in 2021.
RAMM Pharma is a leader in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other hemp-based products with a unique and diversified international production and sales platform. The company operates an established pharmaceutical and medical product business in Uruguay that has developed several medically registered and approved plant-derived cannabinoid pharmaceutical products that have been authorized for sale and/or compassionate use in several Latin American countries.
RAMM also has a pipeline of new products, including registered hemp-based nutrition and specialized veterinary products, in various stages of approval and development, which are produced at the company’s state-of-the-art, good-manufacturing-practice-certified formulation facility in Montevideo, Uruguay.
Print this page